IL-22-expressing CD4+ T cells seen in asymptomatic and mild disease could be associated with tissue-protective responses that may restrict immunopathology (Fig. 3e) as previously shown for IL-22 in influenza A virus infection29 and lower viral load in COVID-19 patients’ lungs30. The gene discussed is CD4; the disease is COVID-19.